Establishment of an innovative staging system for extramedullary plasmacytoma

BACKGROUND: Extramedullary plasmacytoma (EMP) is a rare malignant disease that lacks a unique clinical staging system to predict the survival of EMP patients and to design individualized treatment. Instead, clinicians have chosen to use the multiple myeloma (MM) staging system. METHODS: Forty-eight...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Qian, Zou, Xiong, You, Rui, Jiang, Rou, Zhang, Meng-Xia, Liu, You-Ping, Qian, Chao-Nan, Mai, Hai-Qiang, Hong, Ming-Huang, Guo, Ling, Chen, Ming-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055682/
https://www.ncbi.nlm.nih.gov/pubmed/27717354
http://dx.doi.org/10.1186/s12885-016-2824-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055682/
https://www.ncbi.nlm.nih.gov/pubmed/27717354
http://dx.doi.org/10.1186/s12885-016-2824-x

Ejemplares similares